Impact of developmental pharmacology on pediatric study design: Overcoming the challenges
- 1 September 2000
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 106 (3) , S128-S138
- https://doi.org/10.1067/mai.2000.109419
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cytochrome P450 3AClinical Pharmacokinetics, 1999
- Glucuronidation in HumansClinical Pharmacokinetics, 1999
- Developmental Changes in Urinary Elimination of Theophylline and Its Metabolites in Pediatric PatientsPediatric Research, 1999
- PHARMACOGENETICS IN PEDIATRICSPediatric Clinics of North America, 1997
- Pharmacokinetics and Pharmacodynamics of Famotidine in ChildrenThe Journal of Clinical Pharmacology, 1996
- Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adultsPharmacogenetics, 1995
- Pharmacokinetic and Pharmacodynamic Data Collection in Children and NeonatesClinical Pharmacokinetics, 1992
- Caffeine Acetylator Phenotyping during Maturation in InfantsPediatric Research, 1991
- Cyclosporine Pharmacokinetics in Pediatric Transplant RecipientsTherapeutic Drug Monitoring, 1989
- Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patientThe Journal of Pediatrics, 1980